A stepwise approach for pharmacists: Cardiovascular risk reduction with novel antihyperglycemic agents in patients with type 2 diabetes and atherosclerotic cardiovascular disease
Can Pharm J (Ott). 2020 Dec 10;154(1):30-35.
doi: 10.1177/1715163520976149.
eCollection 2021 Jan-Feb.